Clinical Trials Sponsored by Xintong Pharmacy Company

Total 92 results

Xintong Pharmacy Company

Unknown

To Assess the Anti-anginal Safety and Efficacy of Ivabradine in Subjects With Stable，Symptomatic Chronic Angina

Angina Pectoris

China
VA Pharma Limited Liability Company

Unknown

Reactogenicity, Safety and Immunogenicity of an Universal Influenza Vaccine Uniflu

Safety Issues

Russian Federation
Ten Sun Pharma Company Limited

Completed

Efficacy and Safety of Esarin Gel in Chronic Venous Insufficiency and Varicose Veins

Chronic Venous Insufficiency | Varicose Vein | Superficial Vein Thrombophlebitis

Taiwan
University of Karachi
Hunan Xinhui Pharmacy Limited Company

Completed

Efficacy and Safety of Houtou Jianweiling Tablet in the Treatment of Chronic Non-Atrophic Gastritis (CT)

Gastritis

Pakistan
Sun Pharma Advanced Research Company Limited

Terminated

A Study in Patients With Advanced Breast Cancer

Advanced Breast Cancer | HER2-negative Breast Cancer | Hormone Receptor-positive Breast Cancer

United States, India
Sun Pharma Advanced Research Company Limited

Completed

Study to Determine Safety, Tolerability and Pharmacokinetics, of SCO-120 in Healthy Male and Post-menopausal Female Subjects

Healthy Volunteer Study

United States, Canada
Sun Pharma Advanced Research Company Limited

Completed

Evaluation of Safety of SPARC0913 in Open Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Open Angle Glaucoma

United States
Sun Pharma Advanced Research Company Limited

Completed

Efficacy and Safety of SPARC0912 and Reference0912 in Open Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Open Angle Glaucoma

United States
Sun Pharma Advanced Research Company Limited

Withdrawn

To Assess the Bioavailability and Safety of Paclitaxel Injection Concentrate for Suspension in Subjects With Locally Recurrent or Metastatic Breast Cancer

Metastatic Breast Cancer | Locally Recurrent Cancer

India
Sun Pharma Advanced Research Company Limited

Completed

Efficacy and Safety of SPARC0921 in Subjects With Spasticity

Spasticity

United States, Germany, Hungary, Russian Federation, Ukraine
Sun Pharma Advanced Research Company Limited

Completed

Safety and Efficacy of SPARC1203 in Allergic Rhinitis

Allergic Rhinitis

Germany
Sun Pharma Advanced Research Company Limited

Completed

Bioavailability Study of SPARC001(Study 1) in Healthy Adult Volunteers

Healthy

United States
Sun Pharma Advanced Research Company Limited

Completed

Safety Study of SPARC1104

Spasticity

United States
Sun Pharma Advanced Research Company Limited

Completed

Pharmacokinetic, Safety and Tolerability Study of SPARC1028

Solid Tumor in Advanced Stage

United States
Sun Pharma Advanced Research Company Limited

Completed

Effect of Different Concentrations of SPARC1102 on Allergic Conjunctivitis

Allergic Conjunctivitis

United States
Navire Pharma Inc., a BridgeBio company

Active, not recruiting

First-in-Human Study of the SHP2 Inhibitor BBP-398 in Patients With Advanced Solid Tumors

Tumor, Solid

United States
Sun Pharma Advanced Research Company Limited

Active, not recruiting

PROSEEK: A Phase 2 Study In Early Parkinson's Disease Patients Evaluating The Safety And Efficacy Of Abl Tyrosine Kinase Inhibition Using K0706

Early Parkinson Disease

United States, Spain, India, Hungary, Slovakia, Poland
Sun Pharma Advanced Research Company Limited

Completed

Study of Doxorubicin in Patients With Metastatic Breast Cancer/Advanced Ovarian Cancer

Breast Cancer and Ovarian Cancer
Sun Pharma Advanced Research Company Limited

Withdrawn

A Randomized, Open-Label, Comparative, Parallel-Group, Multicenter Study of SPARC1507

Advanced Biliary Tract Cancer

United States
Sun Pharma Advanced Research Company Limited

Completed

Bioequivalence Study of SPARC147609 in Patients With Ovarian Cancer

Ovarian Carcinoma

India
Sun Pharma Advanced Research Company Limited

Withdrawn

Evaluation of Efficacy and Safety of SPARC1401 in Acute Low Back Pain

Acute Muscle Pain
Sun Pharma Advanced Research Company Limited

Completed

Study of SPARC1103 in Subjects With Spasticity

Spasticity

United States, Russian Federation, Ukraine
Sun Pharma Advanced Research Company Limited

Completed

Pharmacokinetic Study of SPARC1613 and reference1613 in Subjects With Locally Recurrent or Metastatic Breast Cancer

Recurrent or Metastatic Breast Cancer

India
Sun Pharma Advanced Research Company Limited

Terminated

Bioavailability Study of SPARC1210 and Reference1210 in Subjects With Metastatic Breast Cancer

Breast Cancer

India
Sun Pharma Advanced Research Company Limited

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SPARC1316

Asthma

United Kingdom
Sun Pharma Advanced Research Company Limited

Active, not recruiting

Safety and Anti-leukemic Activity of Vodobatinib (K0706) for Treatment of Ph+ CML Resistant/Intolerant to ≥3 Prior CML Therapies

Healthy (For Part A) | Chronic Myeloid Leukemia (for Part B and C)

United States, Spain, Hungary, Italy, India, Belgium, France, Romania, Singapore, United Kingdom, Korea, Republic of, Turkey
Sun Pharma Advanced Research Company Limited

Completed

Evaluation of Safety and Efficacy of PDP-716

Ocular Hypertension | Open Angle Glaucoma

United States
Sun Pharma Advanced Research Company Limited

Completed

Evaluation of Efficacy and Safety of SDN-037

Inflammation and Pain Associated With Ocular Surgery

United States
Sun Pharma Advanced Research Company Limited

Completed

Safety and Tolerability Study of K0706 in Subjects With Parkinson's Disease

Parkinson Disease

United States
Sun Pharma Advanced Research Company Limited

Completed

To Evaluate the Safety, Tolerability and Pharmacokinetics of K0706 in Plasma and Cerebrospinal Fluid in Healthy Volunteers

Healthy

United States
Sun Pharma Advanced Research Company Limited

Completed

Bioavailability Study of SPARC001 (Study 2) in Healthy Adult Volunteers

Healthy

United States
Sun Pharma Advanced Research Company Limited

Completed

A Bioequivalence Study of SPARC_147709 in Patients With Multiple Myeloma

Multiple Myeloma
Sun Pharma Advanced Research Company Limited

Completed

Bioavailability Study of K0706 in Healthy Subjects

Healthy

United States
Sun Pharma Advanced Research Company Limited

Completed

Pharmacokinetic and Safety Study of SPARC1023 Alone and in Carboplatin Combination

Solid Tumor in Advanced Stage

United States
Sun Pharma Advanced Research Company Limited

Completed

Bioavailability Study of SPARC001 in Healthy Adult Volunteers

Healthy
Sun Pharma Advanced Research Company Limited

Completed

Efficacy and Safety of SPARC1310 in Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis

Canada
Sun Pharma Advanced Research Company Limited

Completed

To Evaluate the Relative Abuse Potential of Hydrocodone Bitartrate and Acetaminophen

Healthy

Canada
Pharmtechnology LLC
Algorithme Pharma, An Altasciences Company

Completed

Bioequivalence Study of Two Formulations of Telmisartan 80 mg Tablets in Healthy Adult Volunteers Under Fasting State

Bioequivalence

Canada
Exegi Pharma, LLC
The Emmes Company, LLC

Recruiting

Study of EXE-346 Live Biotherapeutic to Reduce High Bowel Movement Frequency in Subjects With an IPAA (PROF) (PROF)

Ileal Pouch

United States
Navire Pharma Inc., a BridgeBio company
Amgen

Recruiting

SHP2 Inhibitor BBP-398 in Combination With Sotorasib in Patients With Advanced Solid Tumors and a KRAS-G12C Mutation (Argonaut)

Non Small Cell Lung Cancer | Metastatic Solid Tumor | Solid Tumor, Adult | Metastatic NSCLC

Spain, Australia, France, Denmark, Greece, Italy, Netherlands
Eli Lilly and Company
AurKa Pharma Inc.

Completed

A Study of AK-01 (LY3295668) in Solid Tumors

Neoplasms | Breast Neoplasms | Head and Neck Neoplasms | Small Cell Lung Carcinoma | Neoplasm Metastasis | Triple Negative Breast Neoplasms | Solid Tumor, Adult

Canada
Eli Lilly and Company
Roche Pharma AG

Completed

Study of Enzastaurin With 5-Fluorouracil/Leucovorin (5-FU/LV) Plus Bevacizumab as Maintenance Regimen Following First Line Therapy for Metastatic Colon Cancer

Colorectal Cancer

Puerto Rico, United States, Austria, Italy, France, Germany
MEDA PHARMA SPA, a Viatris company

Not yet recruiting

Observational Study to Evaluate Use of Elidel® in South and East Asian Pediatric Patients With Atopic Dermatitis. (Elidel-SEA)

Mild to Moderate Atopic Dermatitis
BMG Pharma
Opera CRO, a TIGERMED Group Company

Recruiting

Evaluation of Safety and Performance of Ialuxid Gel in Treatment of Acne Vulgaris, Impetigo and Folliculitis

Acne Vulgaris | Folliculitis | Impetigo

Romania
Georgetown University
Sun Pharma Advanced Research Company Limited

Recruiting

K0706 for Patients Diagnosed With Dementia With Lewy Bodies

Dementia With Lewy Bodies

United States
SunWave Pharma
Opera CRO, a TIGERMED Group Company

Unknown

Study to Assess the Efficacy and Safety of Endolex Forte VErsus Diosmin and Hesperidin in Reducing VeNous Insufficiency (EVELINE)

Chronic Venous Insufficiency
Huro Biotech Joint Stock Company
Thai Binh University of Medicine and Pharmacy

Completed

Safety Evaluation of Intranasal Use of DSM 32444 Postbiotic in Humans

Rhino Sinusitis

Vietnam
River Pharma S.r.l.
Opera CRO, a TIGERMED Group Company

Completed

Pilot Trial to Assess the Feasibility of Implementing Objective Parameters in Patients Affected by Knee Osteoarthritis (SMILE)

Knee Osteoarthritis

Romania
Mochida Pharmaceutical Company, Ltd.
Sumitomo Pharma (Suzhou) Co., Ltd.

Active, not recruiting

Efficacy of Ethyl Icosapentate in Patients With Severe Hypertriglyceridemia

Hypertriglyceridemia

China
Navire Pharma Inc., a BridgeBio company
Bristol-Myers Squibb

Recruiting

SHP2 Inhibitor BBP-398 in Combination With Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer With a KRAS Mutation

Solid Tumor | Non Small Cell Lung Cancer

United States

Clinical Trials Sponsored by Xintong Pharmacy Company

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Thailand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations